Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Eisai launches Apnission in Japan

July 6, 2004

Japanese launch for Serevent 50 Diskus

July 1, 2004

Phase IIb trial of tgAAVCF for cystic fibrosis cleared to continue

June 29, 2004

Novel LTD4 antagonists and their use reported by Almirall Prodesfarma

June 29, 2004

New HNE inhibitors and their use covered by AstraZeneca patent

June 28, 2004

Mepolizumab reduces allergen-induced eosinophils and tenascin deposition

June 25, 2004

Grelan scientists develop new PDE4 inhibitors for use in respiratory disorders

June 22, 2004

IPL-512602 fails to meet primary endpoint in asthma study

June 22, 2004

Non-antibacterial macrolides with potential as antiiflammatory agents

June 18, 2004

FDA accepts for filing Surfaxin NDA

June 18, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.